Helen M. Boudreau net worth and biography

Helen Boudreau Biography and Net Worth

Director of Premier

Helen M. Boudreau has served as a member of the board of directors of Premier since June 2020. She previously served as Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute and held Chief Financial Officer roles at public and private biotech companies.

Over the course of her more than 30-year career, Boudreau held positions of increasing scope and responsibility in finance in the pharmaceutical industry, including roles as Chief Financial Officer for Novartis Corporation in the U.S., global Chief Financial Officer for Novartis Oncology and senior finance positions at Pfizer Inc. Her experience spans multiple industries and functions, and includes roles at Bank of America, McKinsey & Company, PepsiCo, Pfizer and Novartis.

Boudreau currently serves on the board of directors and as chair of the Audit Committee and member of the Compensation Committee of each of Shattuck Labs Inc., a NASDAQ-listed company, and Field Trip Health Ltd., a company listed on the Canadian Securities Exchange. She also serves on the board of directors of a private biotech. She previously served as a board member and Audit Committee chair for NASDAQ-listed Proteostasis Therapeutics Inc.

Boudreau received a bachelor’s degree from the University of Maryland and an MBA from the Darden School at the University of Virginia.

What is Helen M. Boudreau's net worth?: The estimated net worth of Helen M. Boudreau is at least $401,785.92 as of January 6th, 2025. Boudreau owns 20,668 shares of Premier stock worth more than $401,786 as of April 16th. This net worth approximation does not reflect any other investments that Boudreau may own. Learn More about Helen M. Boudreau's net worth.
How do I contact Helen M. Boudreau?: The corporate mailing address for Boudreau and other Premier executives is 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. Premier can also be reached via phone at (704) 357-0022 and via email at angie_mccabe@premierinc.com. Learn More on Helen M. Boudreau's contact information.
Has Helen M. Boudreau been buying or selling shares of Premier?: Helen M. Boudreau has not been actively trading shares of Premier over the course of the past ninety days. Most recently, Helen M. Boudreau sold 2,500 shares of the business's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $21.42, for a transaction totalling $53,550.00. Following the completion of the sale, the director now directly owns 20,668 shares of the company's stock, valued at $442,708.56. Learn More on Helen M. Boudreau's trading history.
Who are Premier's active insiders?: Premier's insider roster includes Michael Alkire (CEO), Leigh Anderson (Insider), John Bigalke (Director), Helen Boudreau (Director), Andy Brailo (Insider), Stephen D'Arcy (Director), Jody Davids (Director), David Hargraves (SVP), David Klatsky (General Counsel), William Mayer (Director), and Craig Mckasson (CFO). Learn More on Premier's active insiders.
Are insiders buying or selling shares of Premier?: In the last twelve months, insiders at the sold shares 30 times. They sold a total of 363,849 shares worth more than $7,373,385.41. The most recent insider tranaction occured on April, 2nd when General Counsel David L Klatsky sold 10,000 shares worth more than $195,300.00. Insiders at Premier own 1.0% of the company. Learn More about insider trades at Premier.
Information on this page was last updated on 4/2/2025.

Helen M. Boudreau Insider Trading History at Premier

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/6/2025	Sell	2,500	$21.42	$53,550.00	20,668
5/15/2024	Sell	6,629	$19.85	$131,585.65	16,067

Helen M. Boudreau Buying and Selling Activity at Premier

Premier Company Overview

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.

Today's Range

Now: $19.32

$19.25

$19.65

50 Day Range

MA: $18.66

$17.46

$19.68

2 Week Range

Now: $19.32

$17.23

$23.56

Volume

904,658 shs

Average Volume

1,265,747 shs

Market Capitalization

$1.76 billion

P/E Ratio

N/A

Dividend Yield

4.36%

Beta

0.51